,
Sharma, Ricky A.
Plummer, Ruth
Stock, Julie K.
Greenhalgh, Tessa A.
Ataman, Ozlem
Kelly, Stephen
Clay, Robert
Adams, Richard A.
Baird, Richard D.
Billingham, Lucinda
Brown, Sarah R.
Buckland, Sean
Bulbeck, Helen
Chalmers, Anthony J.
Clack, Glen
Cranston, Aaron N.
Damstrup, Lars
Ferraldeschi, Roberta
Forster, Martin D.
Golec, Julian
Hagan, Russell M.
Hall, Emma
Hanauske, Axel-R.
Harrington, Kevin J.
Haswell, Tom
Hawkins, Maria A.
Illidge, Tim
Jones, Hazel
Kennedy, Andrew S.
McDonald, Fiona
Melcher, Thorsten
O'Connor, James P. B.
Pollard, John R.
Saunders, Mark P.
Sebag-Montefiore, David
Smitt, Melanie
Staffurth, John
Stratford, Ian J.
Wedge, Stephen R.
Article History
First Online: 1 June 2016
Competing interests
: R.A.S. has received research funding from Sirtex Technology and consultation fees from Affidea, BTG plc, Cancer Research Technology, Sirtex Medical, and Vertex. O.A. is an employee of Eisai. S.K. and S.B. are employees of Pfizer Ltd. L.B. has received honorarium from Eli Lilly, Pfizer and Roche. G.C. is an employee and shareholder of AstraZeneca. A.N.C. is an employee and stockholder of MISSION therapeutics. L.D. is an employee of Merck KGaA. R.F. is an employee of Astex Pharmaceuticals. J.G. is an employee of Vertex Pharmaceuticals (Europe) Ltd and owns shares in Vertex Pharmaceuticals Inc. R.M.H. is an employee of BTG International Ltd, a manufacturer of specialist healthcare products. A.R.H. is an employee and stock holder of Eli Lilly. T.I. receives research support from AstraZeneca, Medimmune and Roche. T.M. is an employee of Johnson & Johnson. J.R.P. is an employee of, and holds stock in, Vertex Pharmaceuticals. M.S. is an employee of Genentech and stockholder of Roche. I.J.S. is a recipient of a research grant from AstraZeneca. S.R.W. receives research funding from Astex Pharmaceuticals and AstraZeneca. R.P., T.A.G., J.K.S., R.C., R.A.A., R.D.B., S.R.B., H.B., A.J.C., M.D.F., E.H., K.J.H., T.H., M.A.H., H.J., A.S.K., F.M., J.P.B.O'C., M.P.S., D.S-M. and J.S. declare no competing interests.